A trial looking at durvalumab for people with non small cell lung cancer after surgery (MERMAID-2)

This trial is for people with non small cell lung cancer (NSCLC) who:

• have had surgery to completely remove their cancer

• have no sign of cancer on tests and scans after surgery

It is for people who have stage 2 NSCLC, and some people with stage 3 disease.

This trial also looking at measuring small amounts of cancer cells that may be in the bloodstream after surgery. Depending on the results, you may have treatment as part of this trial.